[Suspension of Diane35 and its generics: an over-reaction by the French National Medicines Agency (ANSM) unfounded in the light of proven or accepted medical knowledge].
作者信息
Debarre J-M
出版信息
Ann Dermatol Venereol. 2013 Jun-Jul;140(6-7):474-8. doi: 10.1016/j.annder.2013.04.093. Epub 2013 May 31.
PMID:23773753
Abstract
摘要
相似文献
1
[Suspension of Diane35 and its generics: an over-reaction by the French National Medicines Agency (ANSM) unfounded in the light of proven or accepted medical knowledge].
Ann Dermatol Venereol. 2013 Jun-Jul;140(6-7):474-8. doi: 10.1016/j.annder.2013.04.093. Epub 2013 May 31.
2
[Oral contraceptives, risks and hazards].[口服避孕药，风险与危害]
Ann Dermatol Venereol. 2014 Jan;141(1):5-6. doi: 10.1016/j.annder.2013.12.001. Epub 2014 Jan 10.
3
European Commission orders France to lift ban on acne pill.
BMJ. 2013 Aug 5;347:f4932. doi: 10.1136/bmj.f4932.
4
Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.醋酸环丙孕酮/炔雌醇治疗痤疮和多毛症：是时候修订处方政策了。
Hum Reprod. 2008 Feb;23(2):231-2. doi: 10.1093/humrep/dem379. Epub 2007 Dec 14.
5
Too much disclosure of product risks? CBC television, SOGC, and Diane-35.产品风险披露过多？加拿大广播公司电视台、加拿大妇产科医师学会和达英-35
J Obstet Gynaecol Can. 2003 Apr;25(4):268-9; discussion 270-3. doi: 10.1016/s1701-2163(16)31028-3.
6
Diane-35 (cyproterone acetate): safety concerns.达英-35（醋酸环丙孕酮）：安全性问题。
CMAJ. 2003 Feb 18;168(4):455-6.
7
Specific oral contraceptive use and venous thromboembolism resulting in hospital admission.特定口服避孕药的使用与导致住院的静脉血栓栓塞。
N Z Med J. 2004 Nov 26;117(1206):U1176.
8
9
Cyproterone acetate-ethinyl estradiol use in a 23-year-old woman with stroke.醋酸环丙孕酮 - 炔雌醇在一名23岁中风女性中的应用。
CMAJ. 2014 Jun 10;186(9):690-3. doi: 10.1503/cmaj.130579. Epub 2014 Feb 3.
10
First-use risks.首次使用风险。
CMAJ. 2003 May 27;168(11):1394.
Zotero 插件